132
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 503-508 | Published online: 01 Nov 2019

Figures & data

Figure 1 The Expression of IL-1B- type cytokine of 8 and 16 weeks serial treatment time on kidney (P ANOVA = 0.029).

Figure 1 The Expression of IL-1B- type cytokine of 8 and 16 weeks serial treatment time on kidney (P ANOVA = 0.029).

Figure 2 The Expression of IL-6- type cytokine of 8 and 16 weeks serial treatment time on kidney (P ANOVA = 0.033).

Figure 2 The Expression of IL-6- type cytokine of 8 and 16 weeks serial treatment time on kidney (P ANOVA = 0.033).

Figure 3 Linear regression of kidney IL-1B and IL-6 type cytokine.

Abbreviations: IL-1B, interleukin 1 beta; IL-1B, interleukin 6; aU, arbitrary unit; NC, negative control; DM, diabetes mellitus; DP, darapladib.
Figure 3 Linear regression of kidney IL-1B and IL-6 type cytokine.